The trademark NUROVIT was filed by Reckitt & Colman (Overseas) Health Limited, a corporation established under the laws of the United Kingdom of Great Britain and Northern Ireland (the "Applicant"). The application was published for oppositions on September 12, 2023, and received one opposition filed on December 7, 2023 by Rubimed AG on Likelihood of confusion. the opponent was represented by MANITZ FINSTERWALD PATENT- UND RECHTSANWALTSPARTNERSCHAFT MBB and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued December 7, 2023
The application was filed in Swedish, and Swedish was also language of all opposition proceedings (English was selected as the second language).
Change of name and address of the trademark registration was recorded on September 13, 2023.